Jun 2, 2026 08:01AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
May 15, 2026 08:00AM
May 15, 2026 08:00AM
May 15, 2026 08:00AM INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 13, 2026 08:00AM
May 7, 2026 04:00PM
May 5, 2026 04:00PM INmune Bio expands CORDStrom platform collaboration with Anthony Nolan
May 5, 2026 04:00PM
Apr 30, 2026 08:00AM
Apr 16, 2026 11:42AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM
Mar 30, 2026 04:00PM INmune Bio reports 2025 financial results, plans regulatory filings
Mar 30, 2026 04:00PM
Mar 24, 2026 08:00AM
Mar 19, 2026 08:00AM
Feb 23, 2026 09:25AM
Feb 19, 2026 12:16PM
Feb 19, 2026 12:15PM
Feb 12, 2026 07:01AM INmune Bio receives FDA alignment on phase 2b/3 trial design for alzheimer's drug
Feb 12, 2026 07:00AM
Feb 10, 2026 08:04AM
Feb 10, 2026 08:00AM
Jan 27, 2026 09:25AM
Jan 27, 2026 09:25AM
Dec 5, 2025 07:00AM
Dec 1, 2025 08:03AM INmune Bio presents new imaging data for Alzheimer's drug at CTAD conference
Dec 1, 2025 08:00AM
Dec 1, 2025 08:00AM
Dec 1, 2025 08:00AM
Nov 18, 2025 08:00AM
Oct 30, 2025 04:05PM
Oct 23, 2025 07:00AM
Oct 14, 2025 07:00AM INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
Sep 29, 2025 08:01AM
Sep 29, 2025 08:00AM
Sep 15, 2025 08:00AM
Aug 7, 2025 04:06PM
Aug 7, 2025 04:05PM
Aug 4, 2025 08:14AM
Aug 4, 2025 08:00AM INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
Jul 31, 2025 07:00AM

322,876 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All